Methicillin-Resistant Staphylococcus aureus Bacteremia and Pneumonia

Disease-a-Month

Volumn 54, Issue 12, 2008, Pages 787-792

  Ganesan, Anuradha ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; BACTERIAL SKIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; RISK ASSESSMENT; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, STAPHYLOCOCCAL; PRIMARY PREVENTION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 55249111288     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.09.008     Document Type: Review

References (34)

1. Crane S.J., Uslan D.Z., and Baddour L.M. Bloodstream infections in a geriatric cohort: a population based study. Am J Med 120 12 (2007) 1078-1083
2. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 3 (2004) 309-317
3. Frideman N.D., Kaye J.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 10 (2002) 791-797
4. Libert M., Elkholti M., Massaut J., et al. Risk factors for methicillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 68 1 (2008) 17-24
5. Manzur A., Vidal M., Pujol M., et al. Predictive factors of methicillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect 66 2 (2007) 135-141
6. Cosgrove S.E., Sakoulas G., Perencevich E.N., et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
7. Cosgrove S.E., Qi Y., Kaye K.S., et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26 2 (2005) 166-174
8. Lautenschlager S., Herzog C., and Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin Infect Dis 16 4 (1993) 567-573
9. Petti C.A., and Fowler Jr. V.G. Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am 16 2 (2002) 413-435
10. Melzer M., Eykyn S.J., Gransden W.R., et al. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus?. A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37 11 (2003) 1453-1460
11. Fowler Jr. V.G., Olsen M.K., Corey G.R., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163 17 (2003) 2066-2072
12. Khatib R., Riederer K., Saeed S., et al. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 41 5 (2005) 594-598
13. Chang F.Y., MacDonald B.B., Peacock J.E., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82 5 (2003) 322-332
14. Fowler Jr. V.G., Li J., Corey G.R., et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30 4 (1997) 1072-1078
15. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42 5 (2006) 647-656
16. Popovich K.J., Weinstein R.A., and Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 46 6 (2008) 787-794
17. Huang H., Flynn N.M., King J.H., et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 44 7 (2006) 2423-2427
18. Wang J.L., Chen S.Y., Wang J.T., et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 46 6 (2008) 799-806
19. Steinkraus G., White R., and Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 60 4 (2007) 788-794
20. Moise P.A., Sakoulas G., Forrest A., and Schentag J.J. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 51 7 (2007) 2582-2586
21. Fowler Jr. V.G., Boucher H.W., Corey G.R., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355 7 (2006) 653-665
22. Falagas M.E., Manta K.G., Ntziora F., et al. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 58 2 (2006) 273-280
23. Kollef M.H., Shorr A., Tabak Y.P., et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128 6 (2005) 3854-3862
24. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359 9308 (2002) 753-759
25. Francis J.S., Doherty M.C., Lopatin U., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40 1 (2005) 100-107
26. Gillet Y., Vanhems P., Lina G., et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45 3 (2007) 315-321
27. Weber D.J., Rutala W.A., Sickbert-Bennett E.E., et al. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 28 7 (2007) 825-831
28. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 4 (2005) 388-416
29. Rello J., Torres A., Ricart M., et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 150 6 (1994) 1545-1549
30. Wunderink R.G., Cammarata S.K., Oliphant T.H., et al. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 25 3 (2003) 980-992
31. Rubinstein E., Cammarata S., Oliphant T., et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 32 3 (2001) 402-412
32. Wunderink R.G., Rello J., Cammarata S.K., et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124 5 (2003) 1789-1797
33. Powers J.H., Ross D.B., Lin D., et al. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses. Chest 126 1 (2004) 314-315
34. Micek S.T., Dunne M., and Kollef M.H. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128 4 (2005) 2732-2738